RecruitingNot ApplicableNCT05696561
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery
Sponsor
New World Medical, Inc.
Enrollment
70 participants
Start Date
Sep 9, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma
Eligibility
Min Age: 22 Years
Inclusion Criteria2
- Subjects qualifying for cataract surgery
- Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 22-34 mmHg.
Exclusion Criteria1
- \. Patients who cannot be washed-out of IOP-lowering medications.
Interventions
DEVICECanaloplasty Device
Canaloplasty
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05696561